Clinical Study Results
It was planned that the same participants would be in all 3 parts. But, there were 4 participants who left the study before it ended.

The chart below shows the treatments the participants took.
Part 1: All of the participants took savolitinib as a pill by mouth.
Part 2: All of the participants took rifampicin as a pill by mouth.
Part 3: All of the participants took savolitinib and rifampicin as pills by mouth.

How often did the participants take study treatment?
- Once
- Once a day for 5 days (participants took savolitinib and rifampicin on the first day, and rifampicin only on the second day).

What happened during the study?
The study started in October 2019 and ended in February 2020.

Before the participants took treatment, they visited their study site 1 time over the course of about 1 month. During this visit, the study doctors checked to make sure the participants could join the study. The study doctors:
- Did a physical examination
- Took blood and urine samples
- Checked the participantsâ€™ heart health using an electrocardiogram, also called an ECG
- Asked the participants about their medical history, how they were feeling, and what medicines they were taking.